U.S. Semiconductors Stock News

NYSE:BDX
NYSE:BDXMedical Equipment

BD Product Launches Test Infection Control Story As Shares Weaken

BD (NYSE:BDX) received FDA 510(k) clearance for its Surgiphor 1000mL antimicrobial irrigation system designed for powered lavage, expanding its surgical solutions portfolio. The company also launched the BD Vacutainer Urine Complete Cup Kit, a three tube urine collection system intended to support more consistent sample quality and workflow efficiency. These back to back product milestones highlight ongoing activity in BD's medical and diagnostics franchises that could influence how...
NYSE:ATHM
NYSE:ATHMInteractive Media and Services

Autohome’s New US$200 Million Buyback Amid Weaker 2025 Results Might Change The Case For Investing In Autohome (ATHM)

In March 2026, Autohome Inc. reported past fourth-quarter and full-year 2025 results showing lower revenue and net income year-on-year, while also disclosing that it had repurchased 7,116,939 shares for US$184.50 million under its prior buyback plan. On the same day, the Board authorized a new US$200 million share repurchase program funded from existing cash, underlining management’s commitment to shareholder returns as Autohome advances its AI-driven, online-to-offline automotive service...
NYSE:AGCO
NYSE:AGCOMachinery

Assessing AGCO (AGCO) Valuation After Recent Share Price Pullback

AGCO stock: recent move puts valuation in focus AGCO (AGCO) shares have been under pressure in the past week, with a 9.2% decline following a 2.9% drop in the latest session. This has put fresh attention on the agricultural equipment maker's current valuation and fundamentals. See our latest analysis for AGCO. That sharp 7 day share price return of negative 9.25% comes after a solid 90 day share price return of 17.69% and a 1 year total shareholder return of 21.86%. Recent momentum therefore...
NasdaqGS:RIGL
NasdaqGS:RIGLBiotechs

Assessing Rigel Pharmaceuticals (RIGL) Valuation After Strong Q4 And Full Year 2025 Earnings Results

Rigel Pharmaceuticals (RIGL) is back in focus after reporting fourth quarter and full year 2025 results, with revenue of US$69.8 million for the quarter and net income of US$268.07 million. See our latest analysis for Rigel Pharmaceuticals. Despite the strong Q4 and full year 2025 earnings, Rigel Pharmaceuticals' recent share price performance has been weak, with a 90 day share price return of 40.99% and a year to date share price return of 30.98%, while the 1 year total shareholder return of...
NasdaqGS:JAZZ
NasdaqGS:JAZZPharmaceuticals

Jazz Pharmaceuticals Revenue Record Puts Focus On Zanidatamab And Valuation

Jazz Pharmaceuticals reported record revenues for 2025 and highlighted strong Q4 results. The company completed regulatory filing for zanidatamab in gastroesophageal adenocarcinoma, positioning the therapy for potential approval and launch. Management emphasized ongoing expansion of its rare disease portfolio and upcoming clinical trial readouts. Shares of Jazz Pharmaceuticals (NasdaqGS:JAZZ) recently closed at $182.01, with the stock up 31.1% over the past year and 35.8% over three years...
NYSE:TEN
NYSE:TENOil and Gas

Is Tsakos Energy Navigation (TEN) Pricing Look Stretched After 125% One Year Surge?

If you are trying to figure out whether Tsakos Energy Navigation is attractively priced or not, this article will walk through what the current share price might be implying about the business. The stock most recently closed at US$34.75, with returns of 32.0% over 30 days, 58.7% year to date and 124.7% over the past year, alongside a 1.6% decline over the last week. Recent coverage around Tsakos Energy Navigation has focused on its role in the energy shipping sector and how investors are...
NYSE:CUBI
NYSE:CUBIBanks

Evaluating Customers Bancorp (CUBI) After Recent Share Pullback And Apparent Valuation Discount

Recent share performance sets the stage Customers Bancorp (CUBI) has drawn fresh attention after a recent share pullback, with the stock down about 14% over the past month and roughly 5% over the past 3 months. See our latest analysis for Customers Bancorp. While the recent 14% one month share price pullback and 9.5% year to date share price decline may hint at fading short term momentum, the 34.3% one year total shareholder return and very large 195% three year total shareholder return show...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

CoreWeave Lawsuit Tests Growth Story Of Debt Funding And AI Backlog

CoreWeave (NasdaqGS:CRWV) has been hit with a securities class action lawsuit alleging it overstated its ability to scale and downplayed delays tied to a single data center supplier. At the same time, the company is pursuing debt funded expansion, reporting soft near term revenue guidance, and ramping up large capital expenditures. At a share price of $72.99, CoreWeave is contending with a 7 day return of an 8.3% decline, a 30 day return of an 11.5% decline, and an 8.0% decline year to...
NYSE:VAC
NYSE:VACHospitality

Is Marriott Vacations Worldwide (VAC) Fairly Priced After Recent Share Price Rebound

If you are wondering whether Marriott Vacations Worldwide is priced attractively right now, this article walks through what the current share price might be implying about its value. The stock closed at US$70.50 recently, with returns of 8.4% over the past week, 26.5% over the past month, 19.8% year to date, and 1.4% over the past year, alongside much weaker 3 and 5 year returns of 44.6% and 56.6% declines. These mixed returns mean some investors may see recent strength as a rebound, while...
NYSE:BROS
NYSE:BROSHospitality

How Investors Are Reacting To Dutch Bros (BROS) Nostalgia-Driven Back to Cool Menu Refresh

Dutch Bros recently rolled out its Back to Cool menu nationwide, adding three nostalgic, limited-time drinks such as Brown Butter Chocolate Chip, Fruit Punch with a Sour Candy Straw and Kool Blue across more than 1,136 shops. This push into childhood-inspired flavors highlights how Dutch Bros is leaning into customization and nostalgia to deepen engagement with its predominantly younger, iced-drink-focused customer base. Next, we’ll examine how this nostalgic menu push and broader...
NYSE:DOC
NYSE:DOCHealth Care REITs

Healthpeak Advances Merger Integration And Eyes Janus IPO Value Unlock

Healthpeak Properties (NYSE:DOC) reports progress on integrating a recent merger into its healthcare real estate platform. The company has shifted to an internal management structure, changing how it oversees its portfolio and corporate decisions. Healthpeak is preparing for a potential Janus Living IPO, aimed at surfacing value tied to its senior housing exposure. Healthpeak Properties focuses on healthcare real estate, including assets tied to senior housing, a segment closely watched as...
NasdaqCM:CLSK
NasdaqCM:CLSKSoftware

Why CleanSpark (CLSK) Is Down 7.4% After Weak Q1 Loss And Texas AI Pivot News

CleanSpark, Inc. recently reported unaudited operating results for February 2026, producing 568 bitcoin while progressing the acquisition of a second Texas campus with 300 megawatts of ERCOT-approved capacity. The company sold about 97% of its February bitcoin production to help fund a pivot toward AI and high-performance computing data centers, even as it reported an earnings per share loss of $1.35 in fiscal Q1 2026 versus analyst expectations of $0.26. With CleanSpark expanding into a 300...
NasdaqGS:JKHY
NasdaqGS:JKHYDiversified Financial

Jack Henry (JKHY) Is Up 5.8% After Earnings Beat, 2026 Guidance Hike, Dividend Increase

In recent days, Jack Henry & Associates reported earnings and revenue that exceeded expectations, raised its fiscal 2026 guidance, increased its quarterly dividend to US$0.61 per share, and highlighted product wins such as Financial Crimes Defender’s selection by SELCO Community Credit Union and its addition to the ICBA Preferred Service Provider program. These results, alongside expanding digital asset capabilities through Stablecore’s integration into the Jack Henry Fintech Integration...
NYSE:NOG
NYSE:NOGOil and Gas

What Northern Oil and Gas (NOG)'s Big Impairment, Dividend Hold And 2026 Plans Mean For Shareholders

Northern Oil and Gas, Inc. recently reported its fourth-quarter and full-year 2025 results, showing higher revenue and total production alongside a quarterly net loss driven by a US$268,497,000 impairment of oil and gas assets. At the same time, the company affirmed its quarterly US$0.45 dividend, expanded its revolving credit facility commitments to US$1.80 billion, and issued detailed 2026 production guidance outlining both low- and high-activity development scenarios. Now we’ll examine...
NasdaqGS:SEDG
NasdaqGS:SEDGSemiconductor

SolarEdge Turnaround Hopes Rise On Q4 Progress And Cash Flow Goals

SolarEdge Technologies (NasdaqGS:SEDG) reported strong fourth quarter results, highlighting operational improvements across the business. The company issued guidance for positive free cash flow, pointing to tighter cost control and improved execution. Management is targeting a return to profitability later this year, signaling a potential turnaround after previous challenges. SolarEdge focuses on solar inverters and related energy technologies, so its results often reflect broader trends in...
NYSE:CIVI
NYSE:CIVIOil and Gas

How Weaker 2025 Earnings And Debt Tender At Civitas Resources (CIVI) Has Changed Its Investment Story

Civitas Resources, now part of SM Energy, recently saw SM Energy launch a cash tender offer of up to US$750 million for 8.375% senior notes due 2028 originally issued by Civitas, while also reporting full-year 2025 revenue of US$4,393 million and net income of US$561 million, both lower than the prior year. The combination of weaker annual earnings and SM Energy’s move to refinance inherited Civitas debt highlights how the merger is reshaping the company’s capital structure and cash flow...
NasdaqGS:ENVX
NasdaqGS:ENVXElectrical

Assessing Enovix (ENVX) Valuation After Record Quarterly Revenue And Rising Short Interest

Why Enovix Stock Is Back in Focus After Earnings and Rising Short Interest Enovix (ENVX) is drawing fresh attention after reporting record fourth quarter revenue, ongoing losses and cautious near term guidance, just as short interest has climbed to one of the highest levels among its peers. See our latest analysis for Enovix. Despite record Q4 revenue, Enovix’s 1 day share price return of 3.96% decline and 30 day share price return of 24.34% decline, alongside a 1 year total shareholder...
NYSE:ORI
NYSE:ORIInsurance

Has Old Republic International (ORI) Run Too Far After Strong 5-Year Share Price Performance?

If you are looking at Old Republic International and wondering whether the current share price reflects its true worth, this article walks through the key numbers that can help you frame that question. The stock closed at US$41.82, with returns of 22.1% over 1 year and 176.2% over 5 years. The year-to-date move of 3.4% and the last 7 days at 2.4% lower show that the ride has not been perfectly smooth. Recent coverage of Old Republic International has focused on its position within the US...
NYSE:WY
NYSE:WYSpecialized REITs

Assessing Weyerhaeuser (WY) Valuation After Mixed Returns And Carbon Capture Growth Hopes

What recent performance says about Weyerhaeuser With no single headline event driving attention to Weyerhaeuser (WY) today, investors are instead looking at the stock’s recent return pattern and fundamentals to gauge how the business is currently positioned. Over the past month, Weyerhaeuser’s share price shows an 8.24% decline, while the past 3 months reflect a 12.96% gain. The 1-year total return sits at a 17.98% decline, with a 3-year total return of an 11.06% decline and a 5-year total...
NasdaqGM:ANIP
NasdaqGM:ANIPPharmaceuticals

Is ANI Pharmaceuticals (ANIP) Pricing Reflect Future Cash Flows After Specialty Pharma Headlines

If you are looking at ANI Pharmaceuticals and wondering whether the current share price really reflects its value, this article will walk through the key numbers that matter. The stock last closed at US$74.04, with returns of 0.2% over 7 days, an 8.9% decline over 30 days, a 5.6% decline year to date, and gains of 22.1% over 1 year, 81.2% over 3 years, and 128.9% over 5 years. Recent news coverage has focused on ANI Pharmaceuticals in the context of broader interest in the specialty...
NasdaqGM:FLY
NasdaqGM:FLYAerospace & Defense

Is Firefly Aerospace (FLY) Pricing Reflecting Recent Share Pullback And Growth Expectations

Wondering whether Firefly Aerospace at around US$19.73 is a bargain or a value trap? This article walks through what the current price might be telling you about the stock. The share price has moved 2.4% over the last 7 days, while returns are a 19.2% decline over 30 days and a 17.0% decline year to date. These moves can change how the market is thinking about both growth potential and risk. Recent interest around Firefly Aerospace has been shaped by ongoing coverage of the company’s...
NasdaqGS:VNOM
NasdaqGS:VNOMOil and Gas

Viper Energy Ownership Shifts Raise Questions On Control And Valuation

Viper Energy (NasdaqGS:VNOM) completed a large secondary offering of its Class A common stock by major shareholders, including Diamondback Energy, EnCap Investments, and Oaktree Capital Management. The company is not receiving proceeds from the offering, which was executed at a set offering price. At the same time, Viper is repurchasing units in its operating company from Oaktree affiliates at the same offering price. These moves adjust ownership stakes among key holders and refine how Viper...
NYSE:BBAI
NYSE:BBAIIT

Why BigBear.ai (BBAI) Is Up 7.3% After Mixed Q4 Results And New 2026 Outlook

In early March 2026, BigBear.ai Holdings, Inc. reported Q4 2025 results showing sales of US$27.3 million, a net loss of US$5.83 million, and a US$53.40 million impairment of long‑lived assets, alongside full‑year 2025 sales of US$127.67 million and a net loss of US$293.91 million. At the same time, the company projected full‑year 2026 revenue of US$135 million to US$165 million and highlighted a sharp debt reduction, record liquidity of US$462 million in cash and investments, and recent...
NasdaqCM:SEZL
NasdaqCM:SEZLDiversified Financial

Sezzle Earnings Highlight Shift To AI Powered All In One App

Sezzle (NasdaqCM:SEZL) reported record earnings, highlighting strong revenue and profitability. The company outlined its shift from a pure Buy Now, Pay Later provider to an all-in-one financial app. New offerings such as Sezzle Mobile and AI-driven tools were introduced as part of this broader platform approach. For investors tracking fintech names, Sezzle now appears quite different from its early Buy Now, Pay Later roots. The stock trades at $73.47, with a 1-year return of 88.7% and a...